Advocacy and policy change in the multilevel system of the European Union. A case study within health policy field

Health policy is basically Member States' competence. However, the European Union has recently raised a number of key questions facing both (pharmaceutical) industries and public health interests. By apply- ing the Advocacy Coalition Framework, the paper sheds light on policy change within the European multilevel system. The analysis is based on a case-study strategy. Two processes in the pharmaceutical policy are taken into account: the "Pharma Forum" and the "Pharma Package". They both concern "information to patient"--a controversial policy issue at the crossroad of competing pressures.